Evidence map›Paper›PMID 34669738›Full record

ArticlePLoS genetics2021

Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR.

Anna Hutchinson, Guillermo Reales, Thomas Willis, Chris Wallace

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anna HutchinsonMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-9224-4410
Guillermo RealesCambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9993-3916
Thomas WillisMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-6138-3496
Chris WallaceMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9755-1703
University of Cambridge · GB

Funding

Department of Health BRC-1215-20014Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC UU 00002/4Medical Research Council MC_UU_00002/4Wellcome TrustWellcome Trust WT107881
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified thousands of genetic variants that are associated with complex traits. However, a stringent significance threshold is required to identify robust genetic associations. Leveraging relevant auxiliary covariates has the potential to boost statistical power to exceed the significance threshold. Particularly, abundant pleiotropy and the non-random distribution of SNPs across various functional categories suggests that leveraging GWAS test statistics from related traits and/or functional genomic data may boost GWAS discovery. While type 1 error rate control has become standard in GWAS, control of the false discovery rate can be a more powerful approach. The conditional false discovery rate (cFDR) extends the standard FDR framework by conditioning on auxiliary data to call significant associations, but current implementations are restricted to auxiliary data satisfying specific parametric distributions, typically GWAS p-values for related traits. We relax these distributional assumptions, enabling an extension of the cFDR framework that supports auxiliary covariates from arbitrary continuous distributions ("Flexible cFDR"). Our method can be applied iteratively, thereby supporting multi-dimensional covariate data. Through simulations we show that Flexible cFDR increases sensitivity whilst controlling FDR after one or several iterations. We further demonstrate its practical potential through application to an asthma GWAS, leveraging various functional genomic data to find additional genetic associations for asthma, which we validate in the larger, independent, UK Biobank data resource.

Indexed as

AsthmaGenetic PleiotropyGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMultifactorial InheritancePhenotypePolymorphism, Single Nucleotide

Identifiers

PMID34669738
PMCPMC8559959
OpenAlexW3205182595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.